The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 4, 2026 in Boston Scientific Corporation Lawsuit - BSX
The Gross Law Firm is notifying investors who purchased Boston Scientific Corporation shares between July 2025 and February 2026 of an upcoming lead plaintiff deadline

The Gross Law Firm issued a notice on May 1, 2026, to shareholders of Boston Scientific Corporation regarding an upcoming legal deadline. Investors who purchased shares of the company (NYSE: BSX) during the designated class period are advised that the deadline to apply for a lead plaintiff position is May 4, 2026. This legal action follows allegations of securities fraud or other unlawful business practices affecting the company's stock value.[1][2]
The class period identified in the lawsuit covers the timeframe between July 23, 2025, and February 3, 2026. The Gross Law Firm is encouraging affected shareholders to reach out to discuss possible lead plaintiff appointment. However, the firm notes that being appointed as a lead plaintiff is not a prerequisite for shareholders to partake in any eventual recovery that may be obtained through the litigation process.[1][2]
The allegations in the complaint suggest that Boston Scientific and certain defendants provided investors with overwhelmingly positive statements that were allegedly false or misleading. The lawsuit contends that the company concealed material adverse facts from the public while disseminating information that did not accurately reflect the firm's situation. These actions are claimed to have occurred throughout the specified class period, impacting those who invested in the medical technology company.[1][2]


